Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis

19 Aug 2021

Abstract excerpt

Having been shown to be a biomarker of severity in cystic fibrosis, this study shows SPLUNC1 is also a novel marker of severity and lung infections in non-CF bronchiectasishttps://bit.ly/3ABzEdc

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis Research Advances
Share to Neonatal Respiratory Health Research
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34413156
DOI: 10.1183/13993003.01840-2021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasisPMID 34413156Read ↗

SPLUNC1: A Novel Marker of Cystic Fibrosis ExacerbationsSemantic proximity Read ↗

Differential epithelial expression of the putative innate immune molecule SPLUNC1 in Cystic FibrosisSemantic proximity Read ↗

Bronchiectasis: Phenotyping a Complex Disease.Semantic proximity Read ↗

Increased Susceptibility to Pulmonary Pseudomonas Infection in Splunc1 Knockout MiceSemantic proximity Read ↗

Biomarkers in bronchiectasis.Semantic proximity Read ↗

SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype.Semantic proximity Read ↗

IFRD1 modulates disease severity in cystic fibrosis through the regulation of neutrophil effector functionSemantic proximity Read ↗

Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease.Semantic proximity Read ↗

Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteriaSemantic proximity Read ↗

DLK1 downregulation serves as a potential biomarker for disease severity and a therapeutic target in bronchiectasisSemantic proximity Read ↗

BPIFB1 (LPLUNC1) is upregulated in cystic fibrosis lung diseaseSemantic proximity Read ↗

Differential localisation of BPIFA1 (SPLUNC1) and BPIFB1 (LPLUNC1) in the nasal and oral cavities of miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.